Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

Abstract Purpose of Review Cardiovascular disease (CVD) increasingly afflicts people living
with HIV (PLWH) in the contemporary era of antiretroviral therapy (ART). Coronary artery …

Introduction: Human immunodeficiency virus (HIV) infection is a primary cause of acquired
heart disease, particularly of accelerated atherosclerosis, symptomatic heart failure, and …

The human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
pandemic has entered its 4th decade. Since the introduction of combination antiretroviral …

Human immunodeficiency virus type 1 (HIV-1) is the retrovirus responsible for the
development of AIDS. Its profound impact on the immune system leaves the host vulnerable …

Drug-induced pulmonary arterial hypertension (D-PAH) is a form of World Health
Organization Group 1 pulmonary hypertension (PH) defined by severe small vessel loss and …

We previously demonstrated that the combined exposure of human pulmonary
microvascular endothelial cells (HPMECs) to morphine and viral protein (s) results in the …

Cardiac disease among patients infected with human immunodeficiency virus (HIV) has
drastically changed with the advent and availability of antiretroviral therapy (ART). Early in …

Extracellular vesicles (EVs) have emerged as important mediators in cell–cell
communication; however, their relevance in pulmonary hypertension (PH) secondary to …

Abstract Purpose of Review An increasing body of evidence indicates that persons living
with HIV (PLWH) display dysfunctional immunometabolism. Here, we provide an updated …